FOLLOWUS
1. The Second People’s Hospital Affiliated to Fujian University of Traditional Chinese Medicine,Fuzhou,China
2. The Integrative Institute of Fujian University of Traditional Chinese Medicine,Fuzhou,China
3. Fuzhou General Hospital of Nanjing Military Area,Fuzhou,China
4. Shanxi Provincial Hospital of Traditional Chinese Medicine,Taiyuan,China
5. Union Hospital of Fujian Medical University,Fuzhou,China
6. Xiamen Municipal Hospital of Traditional Chinese Medicine,Fujian Province,China
7. Fuzhou Municipal Hospital of Integrative Medicine,Fuzhou,China
8. Bao’an District Hospital of Traditional Chinese Medicine,Guangdong Province,Shenzhen,China
9. Fujian Provincial People’s Hospital,Fuzhou,China
10. Quanzhou Municipal Hospital of Traditional Chinese Medicine,Fujian,China
11. Xinjing County Hospital of Traditional Chinese Medicine,Sichuan Province,China
纸质出版日期:2010,
网络出版日期:2010-8-10,
Scan for full text
Wu, Mx., Li, Xh., Lin, Mn. et al. Clinical study on the treatment of knee osteoarthritis of Shen (肾)-Sui (髓) insufficiency syndrome type by electroacupuncture., Chin. J. Integr. Med. 16, 291–297 (2010). https://doi.org/10.1007/s11655-010-0513-1
Ming-xia Wu, Xi-hai Li, Mu-nan Lin, et al. Clinical study on the treatment of knee osteoarthritis of Shen (肾)-Sui (髓) insufficiency syndrome type by electroacupuncture[J]. Chinese Journal of Integrative Medicine, 2010,16(4):291-297.
Wu, Mx., Li, Xh., Lin, Mn. et al. Clinical study on the treatment of knee osteoarthritis of Shen (肾)-Sui (髓) insufficiency syndrome type by electroacupuncture., Chin. J. Integr. Med. 16, 291–297 (2010). https://doi.org/10.1007/s11655-010-0513-1 DOI:
Ming-xia Wu, Xi-hai Li, Mu-nan Lin, et al. Clinical study on the treatment of knee osteoarthritis of Shen (肾)-Sui (髓) insufficiency syndrome type by electroacupuncture[J]. Chinese Journal of Integrative Medicine, 2010,16(4):291-297. DOI: 10.1007/s11655-010-0513-1.
To study the clinical effificacy of electroacupuncture (EA) on treating knee osteoarthritis (KOA) of Shen (肾)-Sui (髓) insuffificiency (SSI) syndrome type. A total of 245 patients (279 knees) of KOA-SSI were randomly assigned to two groups by lottery: 141 knees in the treatment group and 138 knees in the control group. The treatment group was managed with EA at the dominant points of Neixiyan (Ex-LE4) and Waixiyan (Ex-LE5) as well as the conjugate points of Xuanzhong (GB39) and Taixi (KI3) for 30 min
once a day
with 15 days as one course; 2 courses were applied with a 5-day interval in between. The control group was treated with intra-articular injection of 2 mL hyaluronic acid into the affected joint every 7 days for 5 times in total. The clinical effects on the patients in different stages were observed
and their symptom scores of knee and contents of cytokines
including interleukin-1 (IL-1)
interleukin-6 (IL-6)
tumor necrosis factor-α (TNF-α)
prostaglandin E2α (PGE2α) and matrix metalloproteinases-3 (MMP-3)
in the knee joint fluid were measured before and after treatment. The study was completed in 235 patients (263 knees); four patients (7 knees) in the treatment group and six patients (9 knees) in the control group dropped out. Comparison of therapeutic effects (excellent and effective rates) between the two groups showed insignificant differences (P>0.05). Symptom scores of knee and contents of cytokines in the knee flfluid after treatment were lowered signifificantly in the patients of stage I–III in both groups (P<0.05 or P<0.01). However
the lowering of the total symptom score of knee in the patients of stage III in the treatment group was more signifificant (P<0.05). EA could effectively alleviate the clinical symptoms in KOA patients of stage III
showing an effect superior to that of hyaluronic acid. EA also shows action in suppressing the secretion of IL-1
IL-6
TNF-α
PGE2α and MMP-3 in the knee flfluid.
To study the clinical effificacy of electroacupuncture (EA) on treating knee osteoarthritis (KOA) of Shen (肾)-Sui (髓) insuffificiency (SSI) syndrome type. A total of 245 patients (279 knees) of KOA-SSI were randomly assigned to two groups by lottery: 141 knees in the treatment group and 138 knees in the control group. The treatment group was managed with EA at the dominant points of Neixiyan (Ex-LE4) and Waixiyan (Ex-LE5) as well as the conjugate points of Xuanzhong (GB39) and Taixi (KI3) for 30 min
once a day
with 15 days as one course; 2 courses were applied with a 5-day interval in between. The control group was treated with intra-articular injection of 2 mL hyaluronic acid into the affected joint every 7 days for 5 times in total. The clinical effects on the patients in different stages were observed
and their symptom scores of knee and contents of cytokines
including interleukin-1 (IL-1)
interleukin-6 (IL-6)
tumor necrosis factor-α (TNF-α)
prostaglandin E2α (PGE2α) and matrix metalloproteinases-3 (MMP-3)
in the knee joint fluid were measured before and after treatment. The study was completed in 235 patients (263 knees); four patients (7 knees) in the treatment group and six patients (9 knees) in the control group dropped out. Comparison of therapeutic effects (excellent and effective rates) between the two groups showed insignificant differences (P>0.05). Symptom scores of knee and contents of cytokines in the knee flfluid after treatment were lowered signifificantly in the patients of stage I–III in both groups (P<0.05 or P<0.01). However
the lowering of the total symptom score of knee in the patients of stage III in the treatment group was more signifificant (P<0.05). EA could effectively alleviate the clinical symptoms in KOA patients of stage III
showing an effect superior to that of hyaluronic acid. EA also shows action in suppressing the secretion of IL-1
IL-6
TNF-α
PGE2α and MMP-3 in the knee flfluid.
osteoarthritiselectroacupunctureclinical effectivenesscytokine
osteoarthritiselectroacupunctureclinical effectivenesscytokine
Wu MX, Zhang FH, Liu XX, Li XH, Lin MN. Discussion on distribution features of TCM syndromes of knee joint osteoarthrits in Fuzhou. J Fujian Univ Tradit Chin Med (Chin) 2008;18(3):37–39.
Zeng HW, Nie B, Shi LL. Observation on therapeutic effect of blood-letting puncture combined with red-hot needle therapy on knee osteoarthritis. Chin Acupunct Moxibustion (Chin) 2008;28:493–495.
Oliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM. Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 1995;38:1134–1141.
Sharif M, George E, Shepstone L, Knudson W, Thonar EJ, Cushnaghan J, et al. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 1995;38:760–767.
State Administration of Traditional Chinese Medicine, P. R. China. Standard for diagnosis and efficacy evaluation of traditional Chinese medicine diseases and syndromes. Nanjing: Nanjing University Press; 1999: 33–36.
Zheng XY, ed. Guiding principle of clinical research on new Drugs of traditional Chinese medicine. Beijing: China Medic-Pharmaceutical Sciences and Technology Publishing House; 2002: 349–353.
Wang C, de Pablo P, Chen X, Schmid C, McAlindon T. Acupuncture for pain relief in patients with rheumatoid arthritis: a systematic review. Arthritis Rheum 2008;59:1249–1256.
Kwon YD, Pittler MH, Ernst E. Acupuncture for peripheral joint osteoarthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 2006;45:1331–1337.
Ahsin S, Saleem S, Bhatti AM, Iles RK, Aslam M. Clinical and endocrinological changes after electro-acupuncture treatment in patients with osteoarthritis of the knee. Pain 2009;147:60–66.
Martel-Pelletier J, Pelletier JP. Osteoarthritis: a single injection of anakinra for treating knee osteoarthritis. Nat Rev Rheumatol 2009;5:363–364.
Daheshia M, Yao JQ. The interleukin 1beta pathway in the pathogenesis of osteoarthritis. J Rheumatol 2008;35:2306–2312.
Vuolteenaho K, Moilanen T, Knowles RG, Moilanen E. The role of nitric oxide in osteoarthritis. Scand J Rheumatol 2007;36:247–258.
Morozzi G, Fabbroni M, Bellisai F, Pucci G, Galeazzi M. Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments. Ann N Y Acad Sci 2007;1108:398–407.
Pujol JP, Chadjichristos C, Legendre F, Bauge C, Beauchef G, Andriamanalijaona R, et al. Interleukin-1 and transforming growth factor-beta 1 as crucial factors in osteoarthritic cartilage metabolism. Connect Tissue Res 2008;9:293–297.
Distel E, Cadoudal T, Durant S, Poignard A, Chevalier X, Benelli C. The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor. Arthritis Rheum 2009;60:3374–3377.
Ferraccioli G, Gremese E. Thrombogenicity of TNF alpha in rheumatoid arthritis defined through biological probes: TNF alpha blockers. Autoimmun Rev 2004;3:261–266.
Livshits G, Zhai G, Hart DJ, Kato BS, Wang H, Williams FM, et al. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: The Chingford Study. Arthritis Rheum 2009;60:2037–2045.
Svetlova MS, Vezikova NN, Romashina VV, Sobanina TS, Pavlov IuL, Chepliukova IA. Content of C-reactive protein, interleukin-1, interleukin-6 and interleukin-1 receptor antagonist in the blood of patients with early osteoarthrosis of the knee. Ter Arkh 2009;81:52–56.
Shin JS, Park N, Ra J, Kim Y, Shin M, Hong M, et al. Panax ginseng C.A. Meyer modulates the levels of MMP3 in S12 murine articular cartilage cell line. J Ethnopharmacol 2009;124:397–403.
Kobayashi A, Naito S, Enomoto H, Shiomoi T, Kimura T, Obata K, et al. Serum levels of matrix metalloproteinase 3 (stromelysin 1) for monitoring synovitis in rheumatoid arthritis. Arch Pathol Lab Med 2007;131:563–570.
Liu XX, Li XH, Zhou JT, Wu MX. Research on mechanism of Tougu Xiaotong Grannule in preventing and treating knee osteoarthrits. Chin J Integr Tradit West Med (Chin) 2007;27:50–54.
0
浏览量
0
Downloads
22
CSCD
关联资源
相关文章
相关作者
相关机构